TINA MATTHEWS-HAYES: Open Payments
NPI 1063726578 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,443 in 159 payments from 8 companies in 2025. Trend: 2023 $229,425 · 2024 $176,082 · 2025 $107,443
Speaker / faculty: $74,690Travel & lodging: $22,914Consulting: $7,360Food & beverage: $2,479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 118 | $98,823 |
| Janssen Pharmaceuticals, Inc | 7 | $5,949 |
| E.R. Squibb & Sons, L.L.C. | 9 | $2,059 |
| Teva Pharmaceuticals USA, Inc. | 16 | $348 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $136 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: VRAYLAR, SPRAVATO, AUSTEDO XR, COBENFY, CAPLYTA, UZEDY, Auvelity, INGREZZA.
Industry payments across VA — which companies pay providers there.
